Check & Inject NY - SEK for BLS Providers

Agency Heads:

The pilot program for Check and Inject has been completed and as a result it has been adopted by the SEMAC for statewide use. The following is a statement made by the SEMAC regarding the program.

"Based on the results of a State Emergency Medical Advisory Committee (SEMAC) demonstration project, the New York State Emergency Medical Service Advisory Council (SEMSCO) approved Syringe Epinephrine for Emergency Medical Technicians (Check & Inject NY) at the September 14, 2016 meeting. The project established that EMTs, with the appropriate training may administer the proper dose of epinephrine for a patient experiencing a severe anaphylactic reaction using a specific 1cc syringe.  Additionally, the project realized a significant cost saving over maintaining epinephrine auto-injectors.  The Commissioner of Health has approved the addition of Syringe Epinephrine and at the request of the SEMAC, this approval includes the intramuscular administration of 1:1000 epinephrine using a 1cc syringe, a 23 gauge, 1 inch intramuscular safety needle and a single dose 1:1000 epinephrine packaged in a 1mg/ml vial as an addition to the scope of practice for an EMT."

You may read the full policy statement down below.

As a result the information needed to complete the training for those that have yet to do so can be found at the following link:

Check and Inject Training Materials

Upon successful completion of your training you must submit a new medical director verification form and submit this to my office no later then one (1) week prior to the next scheduled WREMAC meeting for approval. If you encounter any problems or need an additional help please feel free to reach out to me and I will help you through the process.

Interested agencies in the Genesee, Niagara and Orleans Counties, please contact:

Lake Plains Community Care Network
575 East Main Street
Batavia, NY 14020
Phone: (585)345-6110
Robert McCartin:
Lake Plains Admin,
Aug 3, 2017, 7:30 AM
Lake Plains Admin,
Aug 3, 2017, 7:30 AM